Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes
Authors:
- Jie YuJYJie Yu
- Clare ArnottCAClare Arnott
- Gian Luca Di TannaGTGian Luca Di Tanna
- Maoyi TianMTMaoyi Tian
- Liping HuangLHLiping Huang
- Xuejun YinXYXuejun Yin
- Xinyi ZhangXZXinyi Zhang
- Sallie-Anne PearsonSPSallie-Anne Pearson
- Darwin R. LabartheDLDarwin R. Labarthe
- Paul ElliottPEPaul Elliott
- Lijing L. YanLYLijing L. Yan
- 1 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (5) , 1031-1040
Abstract
BACKGROUND: The SSaSS (Salt Substitute and Stroke Study) has shown that use of a potassium-enriched salt lowers the risk of stroke, total cardiovascular events, and premature death. The effects on cause-specific cardiac outcomes are reported here. METHODS: SSaSS was an unblinded, cluster-randomised trial assessing the effects of potassium-enriched salt compared with regular salt among 20 995 Chinese adults with established stroke and older age and uncontrolled hypertension. Post hoc efficacy analyses were performed using an intention-to-treat method and a hierarchical Poisson regression model adjusting for clustering to obtain rate ratios and 95% CIs. We assessed acute coronary syndrome, heart failure, arrhythmia, and sudden death. RESULTS: Over a mean 4.74 years follow-up, there were 695 acute coronary syndrome events, 454 heart failure events, 230 arrhythmia events, and 1133 sudden deaths recorded. The rates of events were lower in potassium-enriched salt group for all outcomes but CIs were wide for most: acute coronary syndrome (6.32 versus 7.65 events per 1000 person-years; rate ratio, 0.80 [95% CI, 0.65–0.99]); heart failure (9.14 versus 11.32 events per 1000 person-years; rate ratio, 0.88 [95% CI, 0.60–1.28]); arrhythmia (4.43 versus 6.20 events per 1000 person-years; rate ratio, 0.59 [95% CI, 0.35–0.98]); and sudden death (11.01 versus 11.76 events per 1000 person-years; rate ratio, 0.94 [95% CI, 0.82–1.07]; all P >0.05 with adjustment for multiple comparisons). CONCLUSIONS: These results suggest that use of potassium-enriched salt is more likely to prevent than cause cardiac disease but the post hoc nature of these analyses precludes definitive conclusions. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02092090.Keywords
This publication has 24 references indexed in Scilit:
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet, 2021
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2020
- Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2019
- Reduced Salt Intake for Heart FailureJAMA Internal Medicine, 2018
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)—A large-scale cluster randomized controlled trialAmerican Heart Journal, 2017
- Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized TrialsThe American Journal of Medicine, 2017
- The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysisInternational Journal of Cardiology, 2017
- Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failureNutrition, 2004